DPP4 and type 2 diabetes mellitus: In this sense, the current research on T2DM treatment has led to emerging drug therapies like glucagon-like peptide 1 (GLP-1) agonists and dipeptidyl peptidase IV (DPP-IV) enzyme inhibitors [3,6].